Solventum Corporation (SOLV)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.
Key Insights
Share Price
$72.10Market Cap
$12.45 BillionTotal Outstanding Shares
172.71 Million SharesTotal Employees
22,000Dividend
No dividendIPO Date
March 26, 2024SIC Description
Surgical & Medical Instruments & ApparatusHomepage
https://www.3m.com
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
April 1, 2024 to June 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Investing Activities, Continuing | $-58.00 Million |
| Net Cash Flow From Investing Activities | $-58.00 Million |
| Net Cash Flow From Financing Activities, Continuing | $-396.00 Million |
| Net Cash Flow From Financing Activities | $-396.00 Million |
| Net Cash Flow, Continuing | $-99.00 Million |
| Net Cash Flow From Operating Activities | $355.00 Million |
| Net Cash Flow | $-99.00 Million |
| Net Cash Flow From Operating Activities, Continuing | $355.00 Million |
Income Statement
April 1, 2024 to June 30, 2024
| Metric | Value |
|---|---|
| Net Income/Loss Attributable To Parent | $89.00 Million |
| Revenues | $2.08 Billion |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Diluted Earnings Per Share | $0.51 |
| Net Income/Loss Available To Common Stockholders, Basic | $89.00 Million |
| Basic Average Shares | $173.20 Million |
| Diluted Average Shares | $173.50 Million |
| Selling, General, and Administrative Expenses | $701.00 Million |
| Income Tax Expense/Benefit | $7.00 Million |
| Income Tax Expense/Benefit, Deferred | $-31.00 Million |
| Income/Loss From Continuing Operations After Tax | $89.00 Million |
| Research and Development | $192.00 Million |
| Operating Expenses | $893.00 Million |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Basic Earnings Per Share | $0.51 |
| Income/Loss From Continuing Operations Before Tax | $96.00 Million |
| Benefits Costs and Expenses | $1.99 Billion |
| Operating Income/Loss | $244.00 Million |
| Cost Of Revenue | $944.00 Million |
| Net Income/Loss | $89.00 Million |
| Costs And Expenses | $1.84 Billion |
| Gross Profit | $1.14 Billion |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
Balance Sheet
April 1, 2024 to June 30, 2024
| Metric | Value |
|---|---|
| Assets | $14.58 Billion |
| Current Assets | $3.36 Billion |
| Other Non-current Liabilities | $834.00 Million |
| Wages | $198.00 Million |
| Liabilities And Equity | $14.58 Billion |
| Fixed Assets | $1.54 Billion |
| Equity Attributable To Parent | $2.87 Billion |
| Liabilities | $11.71 Billion |
| Equity | $2.87 Billion |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Inventory | $899.00 Million |
| Other Non-current Assets | $6.95 Billion |
| Noncurrent Liabilities | $9.14 Billion |
| Other Current Liabilities | $1.88 Billion |
| Long-term Debt | $8.31 Billion |
| Intangible Assets | $2.72 Billion |
| Other Current Assets | $2.46 Billion |
| Noncurrent Assets | $11.21 Billion |
| Accounts Payable | $495.00 Million |
| Current Liabilities | $2.57 Billion |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ2024 Financhle. All Rights Reserved.